Overview

Clinical Study of Venetoclax Combined With Azacytiside in the Treatment of Myelodysplastic/Myeloproliferative Neoplasms in Adults

Status:
Enrolling by invitation

Trial end date:
2023-02-01

Target enrollment:

Participant gender:

Summary

To explore the efficacy of venetoclax combined with azacytidine in Myelodysplastic / myeloproliferative neoplasms（MDS/MPN）, so as to improve the overall survival and treatment status of MDS/MPN patients.

Phase:

Phase 2

Details

Lead Sponsor:

The First Affiliated Hospital of Soochow University

Treatments:

Azacitidine
Venetoclax